Finance

Lists
MET:NYSE
Metlife Inc
USD 100,24
+0,49%
(+0,49) 1D
15 Okt., 15:32:57 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MET...
Open
USD 100,24
High
USD 100,62
Low
USD 98,62
Mkt. cap
63,70 mjd
Avg. vol.
3,17 m
Volume
1,54 m
Dividend
2,36%
Quarterly dividend
USD 0,59
Ex-dividend date
04 Aug. 2026
P/E ratio
19,18
52-wk high
USD 101,44
52-wk low
USD 67,33
EPS
USD 5,23
Beta
0,78
Shares outstanding
635,48 m
No. of employees
46 k
Open
USD 100,24
High
USD 100,62
Low
USD 98,62
Mkt. cap
63,70 mjd
Avg. vol.
3,17 m
Volume
1,54 m
Dividend
2,36%
Quarterly dividend
USD 0,59
Ex-dividend date
04 Aug. 2026
P/E ratio
19,18
52-wk high
USD 101,44
52-wk low
USD 67,33
EPS
USD 5,23
Beta
0,78
Shares outstanding
635,48 m
No. of employees
46 k
News stories
From web sources and news partners
Profile
MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company, better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue. On January 6, 1915, MetLife completed the mutualization process, changing from a stock life insurance company owned by individuals to a mutual company operating without external shareholders and for the benefit of policyholders. After 85 years as a mutual company, MetLife demutualized into a publicly traded company with an initial public offering in 2000. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia's Pacific region, Europe, and the Middle East. MetLife serves 90 of the largest Fortune 500 companies. Wikipedia
About Metlife Inc
CEOMichel A. Khalaf
Employees46 k
Founded24 Mrt. 1868
HeadquartersNew York Stad, New York, Verenigde State van Amerika
Sector-
Analyst ratings
Based on 12 analysts giving stock ratings to MET in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for MET in the last 3 months.
Highest
Current USD 100,24
USD 119,00 (+18,72%)
Average
USD 111,18 (+10,92%)
Lowest
USD 108,00 (+7,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Pablo Singzon
J.P. Morgan
Buy
Reiterated
USD 110,00
+9,7%
10/15/2026
Wesley Carmichael
Wells Fargo
Buy
Maintained
USD 110,00
+9,7%
10/12/2026
Paul Newsome
Piper Sandler
Buy
Maintained
USD 110,00
+9,7%
10/12/2026
Joshua Shanker
Bank of America Securities
Buy
Maintained
USD 119,00
+18,7%
10/12/2026
Ryan Krueger
KBW
Buy
Maintained
USD 108,00
+7,7%
10/08/2026
Yaron Kinar
Mizuho Securities
Buy
Maintained
USD 109,00
+8,7%
10/07/2026
Alex Scott
Barclays
Buy
Maintained
USD 111,00
+10,7%
10/07/2026
Michael Ward CFA
UBS
Buy
Maintained
USD 110,00
+9,7%
10/06/2026
Bob Huang
Morgan Stanley
Buy
Reiterated
USD 111,00
+10,7%
10/05/2026
Andrew Kligerman
TD Cowen
Buy
Reiterated
USD 110,00
+9,7%
10/05/2026
Suneet Kamath
Jefferies
Buy
Maintained
USD 115,00
+14,7%
10/01/2026
Wilma Burdis
Raymond James
Hold
Maintained
-
-
09/29/2026
Elyse Greenspan
Wells Fargo
Buy
Maintained
USD 109,00
+8,7%
08/19/2026
Unknown Analyst
Raymond James
Hold
Maintained
-
-
06/30/2026
John Barnidge
Piper Sandler
Hold
Maintained
USD 90,00
-10,2%
06/24/2026
Jimmy Bhullar
J.P. Morgan
Buy
Reiterated
USD 96,00
-4,2%
05/12/2026
Thomas Gallagher
Evercore ISI
Hold
Maintained
USD 96,00
-4,2%
04/09/2026
Last report
06 Aug. 2026
Fiscal period
Q2 2026
USD 2,43 / USD 2,29
+6,16%beat
Revenue / Est. (USD)
19,15 mjd / 19,55 mjd
-2,03%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
17,36 mjd
23,81 mjd
19,07 mjd
19,15 mjd
Cost of goods sold
12,90 mjd
19,28 mjd
13,65 mjd
14,54 mjd
Cost of revenue
12,90 mjd
19,28 mjd
13,65 mjd
14,54 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
3,24 mjd
3,42 mjd
3,53 mjd
3,55 mjd
Total operating expenses
16,14 mjd
22,70 mjd
17,18 mjd
18,10 mjd
Operating income
1,22 mjd
1,11 mjd
1,89 mjd
1,06 mjd
Other non operating income
263,00 m
267,00 m
-120,00 m
270,00 m
EBT including unusual items
1,21 mjd
1,12 mjd
1,51 mjd
1,04 mjd
EBT excluding unusual items
1,21 mjd
1,12 mjd
1,51 mjd
1,04 mjd
Income tax expense
308,00 m
301,00 m
345,00 m
256,00 m
Effective tax rate
25,45%
26,95%
22,89%
24,73%
Other operating expenses
3,24 mjd
3,42 mjd
3,53 mjd
3,55 mjd
Net income
896,00 m
809,00 m
1,18 mjd
736,00 m
Net profit margin
5,16%
3,40%
6,21%
3,84%
Earnings per share
2,37
2,49
2,42
2,43
Interest and investment income
-
-
-
-
Interest expense
-271,00 m
-263,00 m
-265,00 m
-292,00 m
Net interest expenses
-271,00 m
-263,00 m
-265,00 m
-292,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,25 mjd
1,78 mjd
1,92 mjd
1,10 mjd
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme